Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Myocardial fibrosis: biomedical research from bench to bedside.
Gyöngyösi M, Winkler J, Ramos I, Do QT, Firat H, McDonald K, González A, Thum T, Díez J, Jaisser F, Pizard A, Zannad F. Gyöngyösi M, et al. Among authors: firat h. Eur J Heart Fail. 2017 Feb;19(2):177-191. doi: 10.1002/ejhf.696. Eur J Heart Fail. 2017. PMID: 28157267 Free PMC article. Review.
Effect of intravenous TRO40303 as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: MITOCARE study results.
Atar D, Arheden H, Berdeaux A, Bonnet JL, Carlsson M, Clemmensen P, Cuvier V, Danchin N, Dubois-Randé JL, Engblom H, Erlinge D, Firat H, Halvorsen S, Hansen HS, Hauke W, Heiberg E, Koul S, Larsen AI, Le Corvoisier P, Nordrehaug JE, Paganelli F, Pruss RM, Rousseau H, Schaller S, Sonou G, Tuseth V, Veys J, Vicaut E, Jensen SE. Atar D, et al. Among authors: firat h. Eur Heart J. 2015 Jan 7;36(2):112-9. doi: 10.1093/eurheartj/ehu331. Epub 2014 Sep 1. Eur Heart J. 2015. PMID: 25179768 Clinical Trial.
Pentraxin 3 in primary percutaneous coronary intervention for ST elevation myocardial infarction is associated with early irreversible myocardial damage : Kinetic profile, relationship to interleukin 6 and infarct size.
Butt N, Bache-Mathiesen LK, Ushakova A, Nordrehaug JE, Jensen SE, Munk PS, Danchin N, Dubois-Rande JL, Hansen HS, Paganelli F, Corvoisier PL, Firat H, Erlinge D, Atar D, Larsen AI. Butt N, et al. Among authors: firat h. Eur Heart J Acute Cardiovasc Care. 2020 Jun;9(4):302-312. doi: 10.1177/2048872620923641. Epub 2020 May 14. Eur Heart J Acute Cardiovasc Care. 2020. PMID: 32403934 Free PMC article. Clinical Trial.
Administration of the Mitochondrial Permeability Transition Pore Inhibitor, TRO40303, prior to Primary Percutaneous Coronary Intervention, Does Not Affect the Levels of Pro-Inflammatory Cytokines or Acute-Phase Proteins.
Butt N, Bache-Mathiesen LK, Nordrehaug JE, Tuseth V, Munk PS, Bonarjee V, Hall TS, Jensen SE, Halvorsen S, Firat H, Atar D, Larsen AI. Butt N, et al. Among authors: firat h. Cardiology. 2017;138(2):122-132. doi: 10.1159/000475460. Epub 2017 Jun 27. Cardiology. 2017. PMID: 28651249 Clinical Trial.
Biomarkers Associated with Atrial Fibrillation in Patients with Ischemic Stroke: A Pilot Study from the NOR-FIB Study.
Tancin Lambert A, Kong XY, Ratajczak-Tretel B, Atar D, Russell D, Skjelland M, Bjerkeli V, Skagen K, Coq M, Schordan E, Firat H, Halvorsen B, Aamodt AH. Tancin Lambert A, et al. Among authors: firat h. Cerebrovasc Dis Extra. 2020;10(1):11-20. doi: 10.1159/000504529. Epub 2020 Feb 6. Cerebrovasc Dis Extra. 2020. PMID: 32028277 Free PMC article.
Translation strategy for the qualification of drug-induced vascular injury biomarkers.
Bendjama K, Guionaud S, Aras G, Arber N, Badimon L, Bamberger U, Bratfalean D, Brott D, David M, Doessegger L, Firat H, Gallas JF, Gautier JC, Hoffmann P, Kraus S, Padro T, Saadoun D, Szczesny P, Thomann P, Vilahur G, Lawton M, Cacoub P. Bendjama K, et al. Among authors: firat h. Toxicol Pathol. 2014 Jun;42(4):658-71. doi: 10.1177/0192623314527644. Epub 2014 Apr 24. Toxicol Pathol. 2014. PMID: 24771082
A generic operational strategy to qualify translational safety biomarkers.
Matheis K, Laurie D, Andriamandroso C, Arber N, Badimon L, Benain X, Bendjama K, Clavier I, Colman P, Firat H, Goepfert J, Hall S, Joos T, Kraus S, Kretschmer A, Merz M, Padro T, Planatscher H, Rossi A, Schneiderhan-Marra N, Schuppe-Koistinen I, Thomann P, Vidal JM, Molac B. Matheis K, et al. Among authors: firat h. Drug Discov Today. 2011 Jul;16(13-14):600-8. doi: 10.1016/j.drudis.2011.04.011. Epub 2011 May 6. Drug Discov Today. 2011. PMID: 21570476 Review.
MicroRNAs: Key Regulators to Understand Osteoclast Differentiation?
Lozano C, Duroux-Richard I, Firat H, Schordan E, Apparailly F. Lozano C, et al. Among authors: firat h. Front Immunol. 2019 Mar 7;10:375. doi: 10.3389/fimmu.2019.00375. eCollection 2019. Front Immunol. 2019. PMID: 30899258 Free PMC article. Review.
Identification of HER-2/neu immunogenic epitopes presented by renal cell carcinoma and other human epithelial tumors.
Scardino A, Alves P, Gross DA, Tourdot S, Graff-Dubois S, Angevin E, Firat H, Chouaib S, Lemonnier F, Nadler LM, Cardoso AA, Kosmatopoulos K. Scardino A, et al. Among authors: firat h. Eur J Immunol. 2001 Nov;31(11):3261-70. doi: 10.1002/1521-4141(200111)31:11<3261::aid-immu3261>3.0.co;2-4. Eur J Immunol. 2001. PMID: 11745343 Free article.
High vaccination efficiency of low-affinity epitopes in antitumor immunotherapy.
Gross DA, Graff-Dubois S, Opolon P, Cornet S, Alves P, Bennaceur-Griscelli A, Faure O, Guillaume P, Firat H, Chouaib S, Lemonnier FA, Davoust J, Miconnet I, Vonderheide RH, Kosmatopoulos K. Gross DA, et al. Among authors: firat h. J Clin Invest. 2004 Feb;113(3):425-33. doi: 10.1172/JCI19418. J Clin Invest. 2004. PMID: 14755339 Free PMC article.
128 results